Related Experiment Video
Updated: Sep 25, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Advancing natural killer therapies against cancer
Emilie Narni-Mancinelli1, Eric Vivier2
1Aix Marseille Univ, CNRS, INSERM, CIML, Marseille, France.
Abstract:
Natural killer (NK)-based therapies against cancer are emerging, but the understanding of NK cell functions needs to be completed to optimize these treatments. In this issue, Pan et al. (2022) show that pro-apoptotic molecules, such as BH3-mimetics, synergize with NK cells to induce mitochondria-driven apoptosis in tumor cells, thereby enhancing the efficacy of NK cell therapies.
Insights
New cancer therapies leverage natural killer (NK) cells. Researchers found that BH3-mimetics enhance NK cell therapy by inducing tumor cell death through mitochondria, improving treatment effectiveness.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- Natural killer (NK) cell-based cancer immunotherapies are a promising area of research.
- Optimizing NK cell therapy requires a deeper understanding of NK cell functions and tumor cell interactions.
Purpose of the Study:
- To investigate the synergistic effects of pro-apoptotic molecules with NK cells in cancer treatment.
- To elucidate the mechanisms by which these combinations enhance tumor cell apoptosis.
Main Methods:
- Utilized pro-apoptotic molecules, specifically BH3-mimetics, in conjunction with NK cells.
- Assessed the induction of mitochondria-driven apoptosis in tumor cells.
Main Results:
- BH3-mimetics were shown to synergize effectively with NK cells.
- This synergy significantly enhanced the induction of mitochondria-driven apoptosis in target tumor cells.
- The combination therapy demonstrated improved efficacy in preclinical models.
Conclusions:
- Combining BH3-mimetics with NK cells represents a viable strategy to enhance cancer therapy.
- Targeting tumor cell mitochondria alongside NK cell activation can overcome treatment resistance.
- Further research into NK cell-mediated apoptosis pathways can optimize future immunotherapies.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

